TheraCryf (LSE:TCF) Days Payable: 0.00 (As of Sep. 2025)

What is TheraCryf Days Payable?

TheraCryf LSE:TCF Days Payable is 0.00 as of Sep. 2025. The stock has 3 warning signs investors should review. Among 705 Biotechnology companies, TheraCryf ranks worse than 141843.83% on this metric.

TheraCryf's average Accounts Payable for the six months ended in Sep. 2025 was £0.96 Mil. TheraCryf's Cost of Goods Sold for the six months ended in Sep. 2025 was £0.00 Mil.

The historical rank and industry rank for TheraCryf's Days Payable or its related term are showing as below:

LSE:TCF's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 113.36
* Ranked among companies with meaningful Days Payable only.

TheraCryf's Days Payable stayed the same from Sep. 2024 (0.00) to Sep. 2025 (0.00).

TheraCryf Days Payable Related Terms

TheraCryf Days Payable Historical Data

* Premium members only.

The historical data trend for TheraCryf's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TheraCryf Days Payable Chart

TheraCryf Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Days Payable

Get a 7-Day Free Trial

0.00

TheraCryf Semi-Annual Data
	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24	Mar25	Sep25
Days Payable	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

LSE:TCF vs VRTX, REGN, ALNY: Days Payable Comparison

For the Biotechnology subindustry, TheraCryf's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TheraCryf Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TheraCryf's Days Payable distribution charts can be found below:

* The bar in red indicates where TheraCryf's Days Payable falls into.

Save Embed

TheraCryf Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

TheraCryf's Days Payable for the fiscal year that ended in Mar. 2025 is calculated as

	Days Payable (A: Mar. 2025 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Mar. 2024 )	+	Accounts Payable (A: Mar. 2025 ))	/	count )	/	Cost of Goods Sold (A: Mar. 2025 )	*	Days in Period
=	( (0.33	+	0.106)	/	2 )	/	0	*	365
=	0.218					/	0	*	365
=	N/A

TheraCryf's Days Payable for the quarter that ended in Sep. 2025 is calculated as:

	Days Payable (Q: Sep. 2025 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Mar. 2025 )	+	Accounts Payable (Q: Sep. 2025 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2025 )	*	Days in Period
=	( (0.106	+	1.816)	/	2 )	/	0	*	365 / 2
=	0.961					/	0	*	365 / 2
=	N/A

Frequently Asked Questions Learn more about Days Payable →

What does a Days Payable of 0.00 mean?

TheraCryf (LSE:TCF) has a Days Payable of 0.00 as of Sep. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on TheraCryf and its competitors. According to the industry distribution chart, TheraCryf ranks #999999 out of 705 companies in the Biotechnology industry.

Is TheraCryf's Days Payable too high?

TheraCryf's current Days Payable is 0.00. Based on the distribution chart, TheraCryf ranks #999999 out of 705 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.

How does TheraCryf's Days Payable compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, TheraCryf ranks #999999 out of 705 companies for Days Payable. This places TheraCryf in the lower half of its industry. The industry median Days Payable is 113.36. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Days Payable for a Biotechnology company?

The median Days Payable among Biotechnology companies is 113.36, based on 705 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Days Payable mean?

A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on TheraCryf and its competitors. For the Biotechnology industry, the median Days Payable is 113.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TheraCryf's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is TheraCryf stock overvalued right now?

TheraCryf (LSE:TCF) has a current Days Payable of 0.00. The current Days Payable is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Days Payable calculated?

Days Payable is calculated from a company's financial statements. For TheraCryf (LSE:TCF), the current Days Payable is 0.00 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TheraCryf Business Description

Industry Healthcare Biotechnology

Comparable Companies LSE:NFX LSE:THAT LSE:FUM LSE:OPTI AQSE:INC LSE:VAL LSE:PYC LSE:BSFA LSE:CRTX LSE:CIZ VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Address Congleton Road, Alderley Park, Nether Alderley, Cheshire, GBR, SK10 4TG

Website https://www.evgen.com

TheraCryf PLC is a clinical stage therapeutics company developing therapeutic candidates for behavioural brain disorders such as opioid and alcohol addiction, and acute/chronic fatigue. It focuses on data generation to support potential partnerships for its programs with mid-sized and large pharmaceutical companies. The company's pipeline includes Ox-1 - Substance Use Disorders (SUDs) / Anxiety, DAT - Fatigue and Narcolepsy, SFX-01, and SFX-01- Neurodevelopmental Disorders.